December 1, 2025Neuro-Oncology

A Novel Prognostic Model for Primary CNS Lymphoma Incorporating Clinico-Laboratory Parameters

View Full Paper

Ask AI

Bookmark

The prognostic model effectively differentiates risk factors for patients with primary CNS lymphoma.
Median overall survival was significantly different across risk groups, highlighting prognostic model efficacy.
Analysis involved 451 patients treated with high-dose methotrexate, establishing baseline and validation cohorts.
The model's optimism-corrected C-index suggests it may serve as a reliable tool for survival prediction.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Prognostic model identifies risk factors and improves overall survival prediction in primary CNS lymphoma patients, suggesting tailored treatment strategies.

Cite This Study

Shin et al. (2025) studied this question.

synapsesocial.com/papers/69402a652d562116f290190a https://doi.org/10.1093/neuonc/noaf275

View Full Paper

Ask AI

Bookmark

Implication

Prognostic model identifies risk factors and improves overall survival prediction in primary CNS lymphoma patients, suggesting tailored treatment strategies.

A Novel Prognostic Model for Primary CNS Lymphoma Incorporating Clinico-Laboratory Parameters

Key Points

Discussion

Implication

Cite This Study

A Novel Prognostic Model for Primary CNS Lymphoma Incorporating Clinico-Laboratory Parameters

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider